Constitutive activity of the histamine H3 receptor

被引:106
作者
Arrang, Jean-Michel [1 ]
Morisset, Severine [1 ]
Gbahou, Florence [1 ]
机构
[1] INSERM, U 573, Ctr Paul Broca, F-75014 Paris, France
关键词
D O I
10.1016/j.tips.2007.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Constitutive activity has been mainly recorded for numerous overexpressed and/or mutated receptors. The histamine H-3 receptor (H3R) is a target of choice to study the physiological relevance of this process. In rodent brain, postsynaptic H(3)Rs show high constitutive activity, and presynaptic H3 autoreceptors that show constitutive activity have a predominant role in inhibiting the activity of histamine neurons. H3R inverse agonists abrogate this constitutive brake and enhance histamine release in vivo. Some of these inverse agonists have entered clinical trials for the treatment of cognitive and food intake disorders. Studies performed in vitro and in vivo with proxyfan show that this H3R ligand is a 'protean agonist' - that is, a ligand with a spectrum of activity ranging from full agonism to full inverse agonism depending on the level of H3R constitutive activity. Consistent with its physiological and therapeutic relevance, the constitutive activity of H3R thus has a major function in the brain and regulates the activity of H3R-targeted drugs.
引用
收藏
页码:350 / 357
页数:8
相关论文
共 68 条
[1]   Histamine and schizophrenia [J].
Arrang, Jean-Michel .
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 :247-+
[2]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[3]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[4]   The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat [J].
Baldi, E ;
Bucherelli, C ;
Schunack, W ;
Cenni, G ;
Blandina, P ;
Passani, MB .
NEUROPHARMACOLOGY, 2005, 48 (02) :246-251
[5]   Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist [J].
Barbier, AJ ;
Berridge, C ;
Dugovic, C ;
Laposky, AD ;
Wilson, SJ ;
Boggs, J ;
Aluisio, L ;
Lord, B ;
Mazur, C ;
Pudiak, CM ;
Langlois, X ;
Xiao, W ;
Apodaca, R ;
Carruthers, NI ;
Lovenberg, TW .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) :649-661
[6]   The physiology of brain histamine [J].
Brown, RE ;
Stevens, DR ;
Haas, HL .
PROGRESS IN NEUROBIOLOGY, 2001, 63 (06) :637-672
[7]   Histamine H3 receptor antagonists reach out for the clinic [J].
Celanire, S ;
Wijtmans, M ;
Talaga, P ;
Leurs, R ;
de Esch, IJP .
DRUG DISCOVERY TODAY, 2005, 10 (23-24) :1613-1627
[8]  
Chidiac P, 1996, MOL PHARMACOL, V50, P662
[9]   Sensitivity of histamine H-3 receptor agonist-stimulated [S-35]GTP gamma[S] binding to pertussis toxin [J].
Clark, EA ;
Hill, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (02) :223-225
[10]   DIFFERENTIAL EFFECT OF SODIUM-IONS AND GUANINE-NUCLEOTIDES ON THE BINDING OF THIOPERAMIDE AND CLOBENPROPIT TO HISTAMINE H-3 RECEPTORS IN RAT CEREBRAL CORTICAL MEMBRANES [J].
CLARK, EA ;
HILL, SJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) :357-362